Concord Biotech consolidated net profit rises 0.26% in the December 2023 quarter

Sales rise 0.05% to Rs 240.80 crore

Net profit of Concord Biotech rose 0.26% to Rs 77.57 crore in the quarter ended December 2023 as against Rs 77.37 crore during the previous quarter ended December 2022. Sales rose 0.05% to Rs 240.80 crore in the quarter ended December 2023 as against Rs 240.68 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales240.80240.68 0 OPM %43.9945.69 -PBDT116.64118.31 -1 PBT103.10104.54 -1 NP77.5777.37 0

Powered by Capital Market - Live News